Effect of onartuzumab added to erlotinib on metastasis in patients with lung cancer

J Clin Oncol. 2014 Nov 20;32(33):3781. doi: 10.1200/JCO.2013.54.3413. Epub 2014 Oct 20.

Authors

Aspasia Soultati¹, Debra H Josephs², James F Spicer³

Affiliations

¹ Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
² Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom and King's College London, London, United Kingdom.
³ Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom and King's College London, London, United Kingdom james.spicer@kcl.ac.uk.

PMID: 25332242
DOI: 10.1200/JCO.2013.54.3413

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Male